Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) (DBCOND0105847)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03414450	Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies	Dasatinib Tinodasertib	treatment	1	withdrawn